Simple product.
Real advantage.

Dropeaz® brings together medical engineering, user experience and materials technology. For pharmaceutical and packaging manufacturers, it is a way to add value to an existing product without changing its formulation.

VALUE
ADD
ONE
PIECE
LOW
RISK
GLOBAL
SCALE

Patient-centric innovation
for ophthalmic products.

From packaging
to experience.

Dropeaz® can become an integral part of a medicinal product set: container, dropper, leaflet, positioner and outer packaging. The partner gains a patient-visible innovation without changing the primary packaging supplier.

LIFE CYCLE

Lifecycle Management

Refresh the lifecycle of an established product and deliver a clear sense of innovation.

BRAND

Brand value

Improve the patient experience, differentiate the portfolio and build long-term loyalty.

OPTIMIZATION

Cost efficiency

Minimal material use, a one-piece design and production in a single manufacturing step.

IMPLEMENTATION

No change to the clean process

Adding the device does not interfere with sterility or validation of the pharmaceutical production line.

Three trends.
One direction.

I

Ageing populations

The growing number of patients with glaucoma, AMD and other eye conditions increases the importance of ergonomic administration.

II

The dry-eye epidemic

Screens and air conditioning are expanding the market for lubricating drops to younger, active users.

III

Patient-centred care

The FDA and EMA are placing greater emphasis on safe, intuitive use by the intended patient population.

35–40bn USD

global ophthalmic drugs market
2024

~17bn USD

ophthalmic drug-delivery systems
2025

3.7bn units

annual ophthalmic packaging production
2024

Indicative values based on industry reports published between 2024 and 2026; methodologies and segment definitions vary between sources.

Flexible models.
A shared objective.

The strategy can be tailored to the partner’s market, portfolio and operational readiness.

01

CORE STRATEGY

Pharma Partnerships

Licensing or supply of finished components and integration of Dropeaz® with Rx and OTC medicines in a co-packaging model.

02

RETAIL CHANNEL

Pharmacies and e-commerce

A standalone accessory for users of artificial tears and patients receiving long-term treatment.

03

MEDICAL CARE

Clinics and post-operative kits

A solution for settings where hygiene and precision are critical to recovery.

Organic growthLicensing modelHybrid model

Low risk.
High scalability.

The project is based on proven PE/PP materials, a simple design and standard injection-moulding technology. It addresses a global problem without the complexity associated with developing a new chemical entity.

Project status

01

Design and engineering

Developed
02

3D prototypes

Completed
03

IP protection

Patent pending
04

Commercialisation strategy

Defined
05

Strategic partnership

In progress

Not another gadget.
Part of the product.

Dropeaz® was designed for integration with medicinal products, broad availability and everyday use.

INTEGRATION

An integral part of the set

The device adds value to the pharmaceutical product instead of functioning as an incidental accessory.

SIMPLICITY

One-piece form

No multi-part assembly by the patient, with the option to leave the device attached to the bottle.

DESIGN

Openwork construction

Unobstructed access to light during administration and reduced material consumption.

SCALABILITY

Low unit cost

One positioner can be dedicated to each bottle, supporting both hygiene and scale.

Let’s discuss
working together.

Product integration, licensing, distribution or investment — together we can select the model best suited to your organisation.

WE ARE INTERESTED IN

Pharma PartnershipPackaging supplierDistributionInvestment
Send an enquiry ↗